NYSE:MTNB
Matinas Biopharma Holdings Inc Stock News
$0.290
+0.0042 (+1.47%)
At Close: Mar 27, 2024
Matinas BioPharma Holdings, Inc. (MTNB) Q3 2023 Earnings Call Transcript
10:44pm, Wednesday, 08'th Nov 2023
Matinas BioPharma Holdings, Inc. (NYSE:MTNB ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Jody Cain - LHA IR Jerry Jabbour - CEO Terri Matkovits - CDO Terry Fergu
Penny Stocks To Buy Now? 3 to Watch With Big News
09:26am, Tuesday, 07'th Nov 2023
Let's talk penny stocks, those under-five-dollar shares that buzz with potential. They're nimble, sensitive to the slightest news, and can pivot on a dime.
Top trending biotech stocks: ANVS, MTNB, AVTX, TPST
11:26am, Thursday, 12'th Oct 2023
Biotech stocks are some of the most volatile in the market because of the regular FDA updates and mergers and acquisitions in the industry. Some of the most notable M&A events this year were Pfizer's
Matinas BioPharma to Present at Two Investment Conferences in October 2023
07:00am, Thursday, 28'th Sep 2023
BEDMINSTER, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of small molec
Matinas BioPharma to Participate in the H.C. Wainwright Global Investment Conference
07:00am, Wednesday, 06'th Sep 2023
BEDMINSTER, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery
BEDMINSTER, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intrace
Matinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023
07:30am, Thursday, 11'th May 2023
BEDMINSTER, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid na
Matinas Biopharma Holdings, Inc. (MTNB) Reports Q1 Loss, Tops Revenue Estimates
06:59pm, Wednesday, 10'th May 2023
Matinas Biopharma Holdings, Inc. (MTNB) came out with a quarterly loss of $0.03 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago.
Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2023 Financial Results and Provide a Business Update on May 10, 2023
07:00am, Wednesday, 03'rd May 2023
BEDMINSTER, N.J., May 03, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery
7 Small-Cap Biotech Stocks with Massive Potential
06:36pm, Thursday, 27'th Apr 2023
While unproven biotechnology firms almost always carry significant risks, small-cap biotech stocks in particular typically impose jaw-dropping volatility. Along with the usual risk of clinical disappo
Matinas BioPharma Holdings, Inc. (MTNB) Q4 2022 Earnings Call Transcript
08:26pm, Wednesday, 15'th Mar 2023
Matinas BioPharma Holdings, Inc. (NYSE:MTNB ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Jody Cain - Investor Relations Jerry Jabbour - Chief Executive Officer Kei
Matinas BioPharma to Webcast Conference Call to Discuss 2022 Financial Results and Provide a Business Update on March 15, 2023
07:00am, Wednesday, 08'th Mar 2023
BEDMINSTER, N.J., March 08, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delive
Matinas BioPharma Holdings, Inc. (MTNB) Q3 2022 Earnings Call Transcript
08:43pm, Wednesday, 02'nd Nov 2022
Matinas BioPharma Holdings, Inc. (NYSE:MTNB ) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Ankit Bhargava - Investor Relations Jerry Jabbour - Chief Executive Offic
Matinas Biopharma Holdings, Inc. (MTNB) Reports Q3 Loss, Misses Revenue Estimates
07:35pm, Wednesday, 02'nd Nov 2022
Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 0% and 0.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for t
10 Top Penny Stocks To Buy For Uner $1 Right Now
01:27pm, Friday, 21'st Oct 2022
Penny stocks to watch under $1 right now. The post 10 Top Penny Stocks To Buy For Uner $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.